We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+20.73%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$498B
AUM Growth
+$25.7B
Cap. Flow
-$8.9B
Cap. Flow %
-1.79%
Top 10 Hldgs %
16.86%
Holding
2,648
New
135
Increased
1,180
Reduced
817
Closed
125

Sector Composition

Rank Sector Weight
1 Healthcare 18.56%
2 Consumer Discretionary 15.28%
3 Financials 14.93%
4 Technology 13.43%
5 Communication Services 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLAC icon
1126
KLA
KLAC
$273B
$20M ﹤0.01%
2,863,850
NKTR icon
1127
Nektar Therapeutics
NKTR
$2.56B
$19.9M ﹤0.01%
77,093
+38,126
+98% +$9.82M
LOGM
1128
DELISTED
LogMein, Inc.
LOGM
$19.9M ﹤0.01%
219,639
+19,670
+10% +$1.58M
CNP icon
1129
CenterPoint Energy
CNP
$26.7B
$19.8M ﹤0.01%
851,198
-16,555,726
-95% -$386M
EXR icon
1130
Extra Space Storage
EXR
$31.6B
$19.6M ﹤0.01%
247,400
+810
+0.3% +$68.4K
CE icon
1131
Celanese
CE
$4.86B
$19.6M ﹤0.01%
294,913
-87,055
-23% -$5.69M
WU icon
1132
Western Union
WU
$2.34B
$19.6M ﹤0.01%
942,639
+1,160
+0.1% +$23.8K
RTEC
1133
DELISTED
Rudolph Technologies Inc
RTEC
$19.6M ﹤0.01%
1,106,090
+1,070,290
+2,990% +$18.1M
RDC
1134
DELISTED
Rowan Companies Plc
RDC
$19.5M ﹤0.01%
1,289,388
+19,200
+2% +$281K
CPB icon
1135
Campbell Soup
CPB
$6.94B
$19.5M ﹤0.01%
356,938
+31,720
+10% +$1.92M
BIO icon
1136
Bio-Rad Laboratories Class A
BIO
$9.66B
$19.5M ﹤0.01%
119,037
+4,800
+4% +$729K
AFSI
1137
DELISTED
AmTrust Financial Services, Inc.
AFSI
$19.5M ﹤0.01%
725,927
+6,839
+1% +$176K
USPH icon
1138
US Physical Therapy
USPH
$1.24B
$19.4M ﹤0.01%
309,785
+28,455
+10% +$1.75M
DHI icon
1139
D.R. Horton
DHI
$41.9B
$19.4M ﹤0.01%
641,410
+46,190
+8% +$1.48M
BBY icon
1140
Best Buy
BBY
$18B
$19.4M ﹤0.01%
506,999
+910
+0.2% +$31.9K
HRL icon
1141
Hormel Foods
HRL
$13.4B
$19.3M ﹤0.01%
509,686
+6,030
+1% +$224K
FCE.A
1142
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$19.2M ﹤0.01%
831,056
+13,330
+2% +$311K
AMG icon
1143
Affiliated Managers Group
AMG
$9.69B
$19.1M ﹤0.01%
132,344
-1,599,746
-92% -$229M
SCAI
1144
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$19M ﹤0.01%
390,667
+52,807
+16% +$2.43M
CCI.PRA
1145
DELISTED
Crown Castle International Corp.
CCI.PRA
$19M ﹤0.01%
169,343
-11,130
-6% -$1.28M
NTAP icon
1146
NetApp
NTAP
$40.2B
$19M ﹤0.01%
530,432
-870
-0.2% -$26.5K
TVTX icon
1147
Travere Therapeutics
TVTX
$5.79B
$19M ﹤0.01%
848,870
+140,181
+20% +$2.67M
HHH icon
1148
Howard Hughes
HHH
$4.04B
$18.9M ﹤0.01%
173,592
+2,413
+1% +$268K
BIG
1149
DELISTED
Big Lots, Inc.
BIG
$18.9M ﹤0.01%
396,668
-4,918
-1% -$252K
MTW icon
1150
Manitowoc
MTW
$753M
$18.9M ﹤0.01%
984,522
+939,720
+2,097% +$19M

Similar funds

T. Rowe Price Associates's Q3 2016 Portfolio in Review

As of Q3 2016, T. Rowe Price Associates held 2,648 positions worth $498B, up 5.4% from $472B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

T. Rowe Price Associates's Q3 2016 filing shows 135 new, 1,180 increased, 817 reduced and 125 closed positions. Its largest new stake was Fortive: 55,770,886 shares worth $1.79B. The largest sale was TotalEnergies, an estimated $8.15B.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q3 2016 buy was Fortive: 55,770,886 shares worth $1.79B.
  • T. Rowe Price Associates added most to PayPal in Q3 2016, an estimated $1.64B increase.
  • T. Rowe Price Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $8.15B.
  • T. Rowe Price Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $1.77B.
  • T. Rowe Price Associates's ten largest holdings make up 17% of its $498B portfolio in Q3 2016.
  • T. Rowe Price Associates opened 135 new positions and closed 125 in Q3 2016.
  • T. Rowe Price Associates's portfolio value rose 5.4% quarter-over-quarter to $498B.

Based on T. Rowe Price Associates's 13F filing for Q3 2016, filed 14 Nov 2016.